Zhengyang Liu

Researcher

Last publication 2025 Last refreshed 2026-05-16

faculty

17 h-index 77 pubs 835 cited

Biography and Research Information

OverviewAI-generated summary

Zhengyang Liu's research focuses on the application of systematic reviews and meta-analyses to investigate clinical outcomes and patient prognosis across various medical specialties. His work has examined the prognostic significance of biomarkers such as neutrophil-lymphocyte ratio and red cell distribution width in cardiac surgery, as well as the epidemiology of persistent postoperative opioid use. Liu has also explored the potential of cell-free DNA as a biomarker for acute myocardial infarction and investigated the duration of antibiotic treatment for complicated appendicitis.

His publication record includes studies on gene therapy for inherited retinal diseases and the role of polyphenols in health, demonstrating a breadth of interest within medical science. Liu has co-authored publications with researchers at the University of Arkansas for Medical Sciences, including Shipra Bansal and Daniel Mak. His scholarship metrics include an h-index of 17, with 77 total publications and 808 total citations.

Metrics

  • h-index: 17
  • Publications: 77
  • Citations: 835

Selected Publications

  • A Structured Framework for Electronic Health Record Optimization: The EASY Program (2026)
  • Trends in Glucagon-Like Peptide 1 Receptor Agonists Utilization for Weight Management in Children (2025)
    2 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

181 Collaborators 60 Institutions 8 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics